Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01225068 · ClinicalTrials.gov registry record · Phase 2
Effect of Milnacipran in Chronic Neuropathic Low Back Pain
A Phase 2 study, sponsored by Northwestern University.
- Completed
- Registry status
- Phase 2
- Development phase
- 40
- Enrollment target
NCT01225068 is a Phase 2 study that has completed, run by Northwestern University. The registered enrollment target is 40 participants.
The verdict
NCT01225068, a Phase 2 study, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 40 participants
- Enrollment target
Study Summary
Low back pain is a public health problem affecting between 70-85% of adults at some time in their life. This study is being done to study the safety and effectiveness of the drug Milnacipran in treating chronic low back pain.
Interventions
- DRUG Placebo
- DRUG Milnacipran
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2010-10 |
| Est. Completion | 2012-04 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01225068
The ClinicalTrials.gov registry entry for NCT01225068 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01225068 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01225068 about?
NCT01225068 is a clinical study titled "Effect of Milnacipran in Chronic Neuropathic Low Back Pain". Low back pain is a public health problem affecting between 70-85% of adults at some time in their life. This study is being done to study the safety and effectiveness of the drug Milnacipran in treating chronic low back pain.
What is the current status of trial NCT01225068?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 40 participants. The study started on 2010-10. Estimated completion is 2012-04.
What interventions are being tested in trial NCT01225068?
The interventions under investigation include: Placebo (DRUG), Milnacipran (DRUG).
Who is sponsoring clinical trial NCT01225068?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.